Marzzoco, A. e Torras, B. (1999). Bioquímica Básica. Rio de Janeiro, Guanabara Koogan S.A.
Guo XF, et al. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials. Clin Nutr. [Em linha].pii: S0261-5614(17)30003-1. (2017).
Erik M. et al. Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application. Progress in Lipid Research. [Em linha].Vol. 66, p. 1-13 (2017). ISSN 0163-7827.
Yanai H. Effects of N-3 Polyunsaturated Fatty Acids on Dementia. Journal of Clinical Medicine Research. [Em linha]. Vol. 9, n.º 1, p. 1-9. (2017).
Abdullah, Al et al. Effect of dietary n-3 fatty acids supplementation on fatty acid metabolism in atorvastatin-administered SHR.Cg-Leprcp/NDmcr rats, a metabolic syndrome model,. Biomedicine & Pharmacotherapy. [Em linha]. Vol. 85, p. 372-379 (2017). ISSN 0753-3322.
Tío L, et al. Effect of chondroitin sulphate on synovitis of knee osteoarthritic patients. Med Clin (Barc). [Em linha]. (2017). pii: S0025-7753(17)30069-6.
Igarashi, M., Sakamoto, K., & Nagaoka, I. Effect of glucosamine on expression of type II collagen, matrix metalloproteinase and sirtuin genes in a human chondrocyte cell line. International Journal of Molecular Medicine. [Em linha]. Vol. 39, n.º2, p. 472-478 (2017).
Wildi LM, et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI Annals of the Rheumatic Diseases. [Em linha]. Vol.70, n.º6, p. 982-989 (2011).
Katia, S et al. Análise da influência da farmacoterapia sobre a qualidade de vida em idosos com osteoartrite. Revista Brasileira de Reumatologia. [Em linha]. Vol. 55, n.º1, p. 83-88 (2015). ISSN 0482-5004.
Milazzo V, et al. Vitamin D and Acute Myocardial Infarction. Word J Cardiol. [Em linha]. Vol.9, n.º1, p. 14–20.(2017).
Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician. [Em linha].Vol.80;N.º2, p. 157-62. (2009).
Barbagallo M., Dominguez L.J. Magnesium and type 2 diabetes. World J. Diabetes.[Em linha].Vol.6, p.1152–1157.(2015).
Jelena P. et al. Magnesium Supplementation Diminishes Peripheral Blood Lymphocyte DNA Oxidative Damage in Athletes and Sedentary Young Man. Oxidative Medicine and Cellular Longevity. [Em linha]. Vol. 2016, Article ID 2019643, 7 pages( 2016).
L. Minutoli et al. Serenoa Repens, Lycopene and Selenium: A Triple Therapeutic Approach to Manage Benign Prostatic Hyperplasia. Current Medicinal Chemistry [Em linha]. Vol. 20,(2013) p.1306-1312.
Wilt T, Ishani A, MacDonald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. [Em linha]. Vol. 3, (2002).
Sahir S. et al. Potential role of Lycopene in targeting Proprotein Convertase Subtilisin/Kexin type-9 to Combat Hypercholesterolemia. Free Radical Biology and Medicine,. [Em linha]. April 2017. ISSN 0891-5849.
Tang, X., et al. Protective effects of lycopene against H2O2-induced oxidative injury and apoptosis in human endothelial cells. Cardiovasc Drugs Ther. [Em linha]. Vol. 23,n.º439 (2009).
